Harvard T.H. Chan School of Public Health at ASHG 2026
Oct 20–24, 2026Montréal, Canada~7.5k attendeesWebsite
Harvard T.H. Chan School of Public Health brings 6 presentations from 4 research groups to ASHG 2026 in Montréal. Its program at this meeting centres on cancer, population genetics, and computational approaches to human disease. The Quackenbush Lab examines biological complexity in sex, aging, health, and disease, the Liang Lab studies polygenic disease associations in individual cells, and the Lin Lab presents integrative genomics of immune regulation across infection, inflammation, and lifespan.
Uses genome and exome sequencing, ChIP-seq, RNA-seq, single-cell RNA-seq and integrated genomic data. Studies gene-regulatory networks in cancer and human disease.
62 papers since 2024
›
Gene regulatory networks reveal sex difference in lung adenocarcinoma
Biology of Sex Differences, 2024
Biologically informed NeuralODEs for genome-wide regulatory dynamics
Genome biology, 2024
Sex-Biased Regulation of Extracellular Matrix Genes in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory Cell and Molecular Biology, 2024
Develops computational tools for metabolomics, DNA methylation and other multi-omics data. Uses longitudinal cohorts to model disease risk and intervention benefit.
105 papers since 2024
›
Optimal dietary patterns for healthy aging
Nature Medicine, 2025
Integration of epidemiological and blood biomarker analysis links haem iron intake to increased type 2 diabetes risk
Nature Metabolism, 2024
Urinary tartaric acid as a biomarker of wine consumption and cardiovascular risk: the PREDIMED trial
Develops statistical and machine-learning methods for whole-genome sequencing, multi-omics, biobank and phenotype data. Uses them for complex-disease risk, causal inference and functional variant analysis.
69 papers since 2024
›
Accelerated biological aging elevates the risk of cardiometabolic multimorbidity and mortality
Nature Cardiovascular Research, 2024
Deciphering the impact of genomic variation on function
Nature, 2024
Whole-genome sequencing in 333,100 individuals reveals rare non-coding single variant and aggregate associations with height
Funded by National Cancer Institute (NCI), National Heart, Lung, and Blood Institute +2 more
›
National Cancer Institute (NCI), Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research · 2015-2029
“Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research (2015-2029) – the National Cancer Institute (NCI)”
National Heart, Lung, and Blood Institute, Statistical Methods for Integrative Analysis of Large-Scale Multi-Ethnic Whole Genome Sequencing Studies and Biobanks of Common Diseases · active
“Statistical Methods for Integrative Analysis of Large-Scale Multi-Ethnic Whole Genome Sequencing Studies and Biobanks of Common Diseases – the National Heart, Lung, and Blood Institute”
National Human Genome Research Institute (NHGRI), Impact of Genomic Variation on Function (IGVF) · active
“Impact of Genomic Variation on Function (IGVF) – Program of the National Human Genome Research Institute (NHGRI)”